AU2001280096A1 - Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same - Google Patents

Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same

Info

Publication number: AU2001280096A1
Authority: AU; Australia
Prior art keywords: metabolism; calcification; polypeptides; vitamin; phosphoric acid
Prior art date: 2000-08-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001280096A

Other versions

AU2001280096B2 (en

Inventor

Seiji Fukumoto

Satoru Mizutani

Takashi Shimada

Takeyoshi Yamashita

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kyowa Kirin Co Ltd

Original Assignee

Kyowa Kirin Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-11

Filing date

2001-08-10

Publication date

2002-05-23

2001-08-10 Application filed by Kyowa Kirin Co Ltd filed Critical Kyowa Kirin Co Ltd

2001-08-10 Priority claimed from PCT/JP2001/006944 external-priority patent/WO2002014504A1/en

2002-05-23 Publication of AU2001280096A1 publication Critical patent/AU2001280096A1/en

2007-03-22 Application granted granted Critical

2007-03-22 Publication of AU2001280096B2 publication Critical patent/AU2001280096B2/en

2007-10-04 Assigned to KIRIN HOLDINGS KABUSHIKI KAISHA reassignment KIRIN HOLDINGS KABUSHIKI KAISHA Request for Assignment Assignors: KIRIN BEER KABUSHIKI KAISHA

2007-11-29 Assigned to KIRIN PHARMA KABUSHIKI KAISHA reassignment KIRIN PHARMA KABUSHIKI KAISHA Request for Assignment Assignors: KIRIN HOLDINGS KABUSHIKI KAISHA

2009-06-04 Assigned to KYOWA HAKKO KIRIN CO., LTD. reassignment KYOWA HAKKO KIRIN CO., LTD. Request for Assignment Assignors: KIRIN PHARMA KABUSHIKI KAISHA

2019-11-07 Assigned to KYOWA KIRIN CO., LTD. reassignment KYOWA KIRIN CO., LTD. Request to Amend Deed and Register Assignors: KYOWA HAKKO KIRIN CO., LTD.

2021-08-10 Anticipated expiration legal-status Critical

Status Expired legal-status Critical Current

Links

AU2001280096A 2000-08-11 2001-08-10 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same Expired AU2001280096B2 (en)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
JP2000-245144		2000-08-11
JP2000245144		2000-08-11
JP2000287684		2000-09-21
JP2000-287684		2000-09-21
JP2000391077		2000-12-22
JP2000-391077		2000-12-22
JP2001-121527		2001-04-19
JP2001121527		2001-04-19
PCT/JP2001/006944 WO2002014504A1 (en)	2000-08-11	2001-08-10	Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2007202461A Division AU2007202461A1 (en)	2000-08-11	2007-05-29	Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same

Publications (2)

Publication Number	Publication Date
AU2001280096A1 true AU2001280096A1 (en)	2002-05-23
AU2001280096B2 AU2001280096B2 (en)	2007-03-22

Family

ID=27481531

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU8009601A Pending AU8009601A (en)	2000-08-11	2001-08-10	Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
AU2001280096A Expired AU2001280096B2 (en)	2000-08-11	2001-08-10	Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU8009601A Pending AU8009601A (en)	2000-08-11	2001-08-10	Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same

Country Status (12)

Country	Link
US (2)	US20040082506A1 (en)
EP (2)	EP2233571B1 (en)
JP (1)	JP4799801B2 (en)
KR (1)	KR100886276B1 (en)
CN (2)	CN100387713C (en)
AT (1)	ATE469217T1 (en)
AU (2)	AU8009601A (en)
CA (1)	CA2418802C (en)
DE (1)	DE60142239D1 (en)
ES (2)	ES2398203T3 (en)
TW (1)	TWI224620B (en)
WO (1)	WO2002014504A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7833529B1 (en)	1999-01-07	2010-11-16	Zymogenetics, Inc.	Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
WO2002014504A1 (en)	2000-08-11	2002-02-21	Kirin Beer Kabushiki Kaisha	Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
US6838264B2 (en)	2000-12-05	2005-01-04	Immutopics, Inc.	Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
US7226749B2 (en)	2000-12-05	2007-06-05	Zahradnik Richard J	Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
MXPA03010687A (en)	2001-05-24	2004-07-01	Zymogentetics Inc	Taci-immunoglobulin fusion proteins.
ATE441666T1 (en) *	2001-12-28	2009-09-15	Kyowa Hakko Kirin Co Ltd	ANTIBODIES AGAINST FIBROBLAST GROWTH FACTOR 23
US7094551B2 (en)	2002-09-17	2006-08-22	Zahradnik Richard J	Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
JP4633552B2 (en) *	2005-06-22	2011-02-16	株式会社テクノメディカ	Kidney function control state measuring method and measuring system
AU2006278229B2 (en)	2005-08-09	2011-10-27	Ares Trading S.A.	Methods for treating B-cell malignancies using TACI-Ig fusion molecule
UA98462C2 (en)	2006-05-15	2012-05-25	Арес Трейдинг С.А.	Methods for treating autoimmune diseases using a taci-ig fusion molecule
US8012694B2 (en)	2006-09-14	2011-09-06	Immutopics, Inc.	Assay for the detection of phosphorylated PTH
US7883705B2 (en)	2007-02-14	2011-02-08	Kyowa Hakko Kirin Co., Ltd.	Anti FGF23 antibody and a pharmaceutical composition comprising the same
WO2009133905A1 (en) *	2008-04-28	2009-11-05	協和発酵キリン株式会社	Peptide capable of inhibiting activity of human fibroblast growth factor-23 (human fgf-23), and pharmaceutical composition comprising the same
CN101891814B (en) *	2009-05-21	2012-11-07	中国科学院上海生命科学研究院	Anti-osteopontin OPN monoclonal antibody and application thereof
WO2012050673A1 (en)	2010-10-14	2012-04-19	Wisconsin Alumni Research Foundation	Methods for the treatment of x-linked hypophosphatemia and related disorders
SI3845245T1 (en)	2014-06-09	2025-10-30	Ultragenyx Pharmaceutical Inc.	The effective and efficient control of serum phosphate for optimal bone formation
CN105688185B (en) *	2016-03-13	2019-03-19	浙江药苑生物科技有限公司	A kind of pharmaceutical composition for treating bone marrow hyperplasia and bone cancer and use thereof
WO2018069232A1 (en)	2016-10-10	2018-04-19	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods for predicting the risk of having cardiac hypertrophy
CN109601477A (en) *	2018-12-21	2019-04-12	云南农业大学	A method for breeding Wuding chickens based on vitamin D receptor blood biochemical markers
CN115902234A (en) *	2022-09-07	2023-04-04	山西农业大学	A liver metabolite detection marker composition for detecting calcium and phosphorus metabolism disorders in sheep under natural grazing

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1985003934A1 (en)	1984-03-06	1985-09-12	Takeda Chemical Industries, Ltd.	Chemically modified protein and process for its preparation
GB8308235D0 (en)	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
NZ226694A (en)	1987-10-28	1994-04-27	Oncogen	Human immunoglobulin produced by recombinant dna techniques
JP2958019B2 (en)	1988-05-06	1999-10-06	住友製薬株式会社	Polyethylene glycol derivative, modified peptide and method for producing the same
US5530101A (en) *	1988-12-28	1996-06-25	Protein Design Labs, Inc.	Humanized immunoglobulins
CN1047086A (en) *	1989-03-16	1990-11-21	大制药株式会社	Polypeptide derivative and improve agent of calcium metabolism
US5958879A (en) *	1989-10-12	1999-09-28	Ohio University/Edison Biotechnology Institute	Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal
CN1229385C (en)	1994-03-31	2005-11-30	安姆根有限公司	Compositions and methods for stimulating growth and differentiation of megakaryocytes
US6001358A (en) *	1995-11-07	1999-12-14	Idec Pharmaceuticals Corporation	Humanized antibodies to human gp39, compositions containing thereof
CA2285554A1 (en) *	1997-03-25	1998-10-01	Genetics Institute, Inc.	Secreted proteins and polynucleotides encoding them
ATE354656T1 (en)	1998-05-18	2007-03-15	Univ London	HUMAN TUMOR-DERIVED POLYPEPTIDE HORMONE PHOSPHATONIN
TWI255853B (en)	1998-08-21	2006-06-01	Kirin Brewery	Method for modifying chromosomes
JP2000287684A (en)	1999-02-05	2000-10-17	Asahi Breweries Ltd	Nucleotide sequence of chromosome region 9p11 involved in cancer and miscarriage
JP3490327B2 (en)	1999-02-19	2004-01-26	東光株式会社	Switching power supply
AU3924300A (en)	1999-04-02	2000-10-23	Millennium Pharmaceuticals, Inc.	Fibroblast growth factor-20
US6596849B1 (en) *	1999-05-28	2003-07-22	Academia Sinica	Monoclonal-antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules
AU3774300A (en) *	1999-06-02	2000-12-18	Genentech Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2001121527A (en)	1999-10-29	2001-05-08	Asahi Glass Co Ltd	Composite panel and its manufacturing method
CA2496312A1 (en) *	1999-12-01	2001-06-07	Kevin P. Baker	Colon tumour marker pro4799 polypeptides and nucleic acids encoding the same
EP1252305A2 (en) *	1999-12-08	2002-10-30	Genset	Full-length human cdnas encoding potentially secreted proteins
EP1246843A1 (en) *	2000-01-05	2002-10-09	ZymoGenetics, Inc.	Novel fgf homolog zfgf12
EP1255771A4 (en) *	2000-02-14	2004-09-29	Smithkline Beecham Corp	Novel compounds
US20060160181A1 (en) *	2000-02-15	2006-07-20	Amgen Inc.	Fibroblast Growth Factor-23 molecules and uses thereof
JP2005508131A (en) *	2000-02-15	2005-03-31	アムジェンインコーポレイテッド	Fibroblast growth factor-23 molecule and uses thereof
AU2001245535A1 (en) *	2000-03-08	2001-09-17	Chiron Corporation	Human fgf-23 gene and gene expression products
EP1261638A2 (en) *	2000-03-08	2002-12-04	Chiron Corporation	Human fgf-23 gene and gene expression products
EP2184296A1 (en) *	2000-07-19	2010-05-12	Advanced Research And Technology Institute, Inc.	Fibroblast growth factor (fgf23) and methods for use
WO2002014504A1 (en)	2000-08-11	2002-02-21	Kirin Beer Kabushiki Kaisha	Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
ES2295228T3 (en)	2000-11-30	2008-04-16	Medarex, Inc.	TRANSGROMIC TRANSCROMOSOMIC ROLLERS FOR THE PREPARATION OF HUMAN ANTIBODIES.
WO2002076467A1 (en)	2001-03-22	2002-10-03	Genzyme Corporation	Compositions and methods to regulate bone and mineral metabolism
US20040171825A1 (en) *	2001-04-26	2004-09-02	Lydie Bougueleret	Human fibroblast growth factor-related compositions
ATE441666T1 (en)	2001-12-28	2009-09-15	Kyowa Hakko Kirin Co Ltd	ANTIBODIES AGAINST FIBROBLAST GROWTH FACTOR 23
US7094551B2 (en) *	2002-09-17	2006-08-22	Zahradnik Richard J	Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
JPWO2006078072A1 (en)	2005-01-21	2008-06-19	キリンファーマ株式会社	Chimeric non-human animals and uses thereof
WO2008057683A2 (en)	2006-10-03	2008-05-15	Novo Nordisk A/S	Methods for the purification of polypeptide conjugates
WO2008092019A1 (en)	2007-01-25	2008-07-31	Mayo Foundation For Medical Education And Research	Fgf-23 polypeptides
US7883705B2 (en) *	2007-02-14	2011-02-08	Kyowa Hakko Kirin Co., Ltd.	Anti FGF23 antibody and a pharmaceutical composition comprising the same

2001
- 2001-08-10 WO PCT/JP2001/006944 patent/WO2002014504A1/en not_active Ceased
- 2001-08-10 EP EP10163562A patent/EP2233571B1/en not_active Expired - Lifetime
- 2001-08-10 EP EP01958379A patent/EP1310554B1/en not_active Expired - Lifetime
- 2001-08-10 KR KR1020037001931A patent/KR100886276B1/en not_active Expired - Lifetime
- 2001-08-10 JP JP2002519632A patent/JP4799801B2/en not_active Expired - Lifetime
- 2001-08-10 ES ES10163562T patent/ES2398203T3/en not_active Expired - Lifetime
- 2001-08-10 CN CNB018172962A patent/CN100387713C/en not_active Expired - Lifetime
- 2001-08-10 AU AU8009601A patent/AU8009601A/en active Pending
- 2001-08-10 AU AU2001280096A patent/AU2001280096B2/en not_active Expired
- 2001-08-10 AT AT01958379T patent/ATE469217T1/en not_active IP Right Cessation
- 2001-08-10 CN CNA2008100866831A patent/CN101275136A/en active Pending
- 2001-08-10 ES ES01958379T patent/ES2344679T3/en not_active Expired - Lifetime
- 2001-08-10 CA CA2418802A patent/CA2418802C/en not_active Expired - Lifetime
- 2001-08-10 DE DE60142239T patent/DE60142239D1/en not_active Expired - Lifetime
- 2001-08-10 TW TW090119818A patent/TWI224620B/en not_active IP Right Cessation
- 2001-08-10 US US10/344,339 patent/US20040082506A1/en not_active Abandoned
2008
- 2008-12-01 US US12/325,551 patent/US7981419B2/en not_active Expired - Fee Related

Publication	Publication Date	Title
AU2001280096A1 (en)	2002-05-23	Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same
AU2002364556A1 (en)	2003-07-24	Power supply control system
AUPQ899700A0 (en)	2000-08-17	Probiotic recolonisation therapy
AU2001288024A1 (en)	2003-03-18	Dose control in ct-images
AU2001283170A1 (en)	2002-02-18	Control valves
ZA200206779B (en)	2003-04-15	Solid formulation.
AU2001242306A1 (en)	2001-10-03	Control valve
AU2001264852A1 (en)	2001-12-03	Lactobacillusbeta -glucuronidase and dna encoding the same
AU2002343025A1 (en)	2003-06-10	Improvements in footwear
EP1467265B8 (en)	2009-07-08	Control system
GB0108516D0 (en)	2001-05-23	Power control
AU2001260104A1 (en)	2001-09-17	Control valve
ZA200002660B (en)	2000-11-29	Ectoparasite control composition.
EP1251277A3 (en)	2004-03-31	Pressure averaging power control system
GB0119712D0 (en)	2001-10-03	Control valves
GB2374730B (en)	2003-06-18	Control
AU7101700A (en)	2001-03-26	Human calcium dependent proteases and polynucleotides encoding the same
GB2381104B (en)	2005-08-10	Acoustically-activated control system
AUPR749701A0 (en)	2001-09-27	Vitamin deficiency
AUPR616501A0 (en)	2001-08-02	Vitamin deficiency
AU2001282789A1 (en)	2002-03-04	Control valve
GB0112927D0 (en)	2001-07-18	Control valve
AU2001241673A1 (en)	2001-09-03	Novel human regulatory protein and polynucleotides encoding the same
GB0013959D0 (en)	2000-08-02	Dietary control
GB0127651D0 (en)	2002-01-09	Power control for two or more similar resistive loads